10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial.
- Resource Type
- Article
- Source
- BMJ Open; May2020, Vol. 10 Issue 5, p1-11, 11p
- Subject
- Language
- ISSN
- 20446055